WALTHAM, Mass., June 10, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (APLS) today announced that SYFOVRE ® (pegcetacoplan injection) preserved visual function at 36 months in patients with ...

SYFOVRE is the only approved GA treatment to demonstrate a visual function benefit in a prespecified endpoint Data presented at the Clinical Trials at the Summit Meeting In a prespecified ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Results presented at the American Academy of Orthopaedic Surgeons Annual Meeting showed hyaluronic ...

HOUSTON--(BUSINESS WIRE)--Results of a U.S. FDA-approved, randomized controlled feasibility study on treatment of symptomatic partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, ...

Platelet-rich plasma (PRP) injections into the anterior vaginal wall enhanced sexual function in premenopausal women without severe sexual dysfunction. At 6 months, more than two thirds of women ...